Biomedical subjects
R Montero Benzo
Publications and source records attributed to R Montero Benzo.
[Comparative study of propanidid and midazolam, a new anesthesia induction agent].
Explore the source record for details and available documents.
[Nitroglycerin via continuous perfusion in postoperative resuscitation in heart surgery. A hemodynamic study].
Explore the source record for details and available documents.
[Anaesthesia and resucitation in a case of inadvertent pheochromocytoma in an atypical location (author's transl)].
Explore the source record for details and available documents.
[Efficacy of intravenous non-specific immunoglobulins in the therapy of septicaemias (author's transl)].
Explore the source record for details and available documents.
[Intensive care in severe tetanus in a pregnant patient].
Explore the source record for details and available documents.
[Nitroglycerin in controlled hypotension in neurosurgery].
Explore the source record for details and available documents.
[Thrombogenesis and coagulolysis as affected by alfathesin].
Explore the source record for details and available documents.
[Postoperative resuscitation in a case of removal of ventricular postinfarction aneurysm with mitral valve replacement (author's transl)].
Explore the source record for details and available documents.
[Dobutamine in low cardiac output syndrome. Haemodynamic study (author's transl)].
Explore the source record for details and available documents.
[A study of the alveolar-arterial oxygen gradients and intrapulmonary shunt under the action of NAB-365, a new exogenous catecholamine of selective beta-2 action (author's transl)].
Thirty patients were studied using NAB-365 (clenbuterol), an exogenous catecholamine with selective beta-2 action to determine various parameters of pulmonary physiopathology. They included: alveolar-arterial gradients in partial oxygen pressures, coefficient of respiratory inefficacy, alveolar ventilation, and intrapulmonary venoarterial short circuits. By studying these parameters before and after clinical administration of clenbuterol we were able to demonstrate a decrease in the alveolar-arterial oxygen gradients (p less than 0.001), decrease in the respiratory inefficacy coefficient (p less than 0.001), increase in alveolar ventilation (p less than 0.001), and a shunt decrease (p less than 0.0025). The drug improves diffusion and oxygenation without affecting the adrenergic cardiac receptors.
[Use of pulmonary extracorporeal circulation in a case of refractary hypoxemia].
Explore the source record for details and available documents.
[Study of the functional activity of the reticuloendothelial system in normal conditions and under ethrane anesthesia].
Explore the source record for details and available documents.
[Intrapulmonary shunt under the action of sodium nitroprusside].
Explore the source record for details and available documents.
[Study of flunitrazepam in heart surgery with C.E.C. Metabolic and respiratory aspects].
Explore the source record for details and available documents.
[Influence of surgery and fluid therapy in the immunological process. Aspects of immediate-action intravenous gamma globulin therapy].
Explore the source record for details and available documents.
[Electrocardiographic study in patients with severe tetary].
Explore the source record for details and available documents.
[Changes of renal function in hypocapnia].
Explore the source record for details and available documents.